Search research articles
Contact Us
Filters
Showing results (71-80 of 121) with videos related to
Page
of 13
Sort By:
Cancer Research
|
November 17, 2005
Reliable high-throughput genotyping and loss-of-heterozygosity detection in formalin-fixed, paraffin-embedded tumors using single nucleotide polymorphism arrays
Esther H Lips, Jan Willem F Dierssen, Ronald van Eijk, et al.
NPJ Breast Cancer
|
May 6, 2022
Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance
Marlous Hoogstraat, Esther H Lips, Isabel Mayayo-Peralta, et al.
Breast Cancer Research : BCR
|
June 3, 2014
Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy
Marieke A Vollebergh, Esther H Lips, Petra M Nederlof, et al.
Genome Research
|
April 28, 2009
The colorectal cancer risk at 18q21 is caused by a novel variant altering SMAD7 expression
Alan M Pittman, Silvia Naranjo, Emily Webb, et al.
The Journal of Pathology
|
May 23, 2024
Ductal carcinoma in situ develops within clonal fields of mutant cells in morphologically normal ducts
Stefan J Hutten, Hendrik A Messal, Esther H Lips, et al.
JCO Precision Oncology
|
September 22, 2023
Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide Cohort
Tessa G Steenbruggen, Denise M Wolf, Bram Thijssen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2024
Locoregional Breast Cancer Recurrence in the European Organisation for Research and Treatment of Cancer 10041/BIG 03-04 MINDACT Trial: Analysis of Risk Factors Including the 70-Gene Signature
Sena Alaeikhanehshir, Taiwo Ajayi, Frederieke H Duijnhoven, et al.
Breast Cancer Research and Treatment
|
May 4, 2021
Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer
Emma J Groen, Marieke E M van der Noordaa, Michael Schaapveld, et al.
NPJ Breast Cancer
|
March 23, 2021
Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ
Mathilde M M Almekinders, Michael Schaapveld, Bram Thijssen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2008
Progression and tumor heterogeneity analysis in early rectal cancer
Esther H Lips, Ronald van Eijk, Eelco J R de Graaf, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 121) with videos related to
Sort By:
Page
of 13
Cancer Research
|
November 17, 2005
Reliable high-throughput genotyping and loss-of-heterozygosity detection in formalin-fixed, paraffin-embedded tumors using single nucleotide polymorphism arrays
Esther H Lips, Jan Willem F Dierssen, Ronald van Eijk, et al.
NPJ Breast Cancer
|
May 6, 2022
Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance
Marlous Hoogstraat, Esther H Lips, Isabel Mayayo-Peralta, et al.
Breast Cancer Research : BCR
|
June 3, 2014
Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy
Marieke A Vollebergh, Esther H Lips, Petra M Nederlof, et al.
Genome Research
|
April 28, 2009
The colorectal cancer risk at 18q21 is caused by a novel variant altering SMAD7 expression
Alan M Pittman, Silvia Naranjo, Emily Webb, et al.
The Journal of Pathology
|
May 23, 2024
Ductal carcinoma in situ develops within clonal fields of mutant cells in morphologically normal ducts
Stefan J Hutten, Hendrik A Messal, Esther H Lips, et al.
JCO Precision Oncology
|
September 22, 2023
Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide Cohort
Tessa G Steenbruggen, Denise M Wolf, Bram Thijssen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2024
Locoregional Breast Cancer Recurrence in the European Organisation for Research and Treatment of Cancer 10041/BIG 03-04 MINDACT Trial: Analysis of Risk Factors Including the 70-Gene Signature
Sena Alaeikhanehshir, Taiwo Ajayi, Frederieke H Duijnhoven, et al.
Breast Cancer Research and Treatment
|
May 4, 2021
Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer
Emma J Groen, Marieke E M van der Noordaa, Michael Schaapveld, et al.
NPJ Breast Cancer
|
March 23, 2021
Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ
Mathilde M M Almekinders, Michael Schaapveld, Bram Thijssen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2008
Progression and tumor heterogeneity analysis in early rectal cancer
Esther H Lips, Ronald van Eijk, Eelco J R de Graaf, et al.
Page
of 13